Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone-Reference-Cited by-同舟云学术

Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone

Published:2022-12-21 Issue:1 Volume:46 Page:59-64
ISSN:0253-6269
Container-title:Archives of Pharmacal Research
language:en
Short-container-title:Arch. Pharm. Res.

Author:

Cho Chang‑Keun,Byeon Ji-Young,Kang Pureum,Park Jung-In,Jang Choon-Gon,Lee Seok-Yong^ORCID,Choi Chang-Ik,Bae Jung‑Woo,Lee Yun Jeong

Funder

National Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Drug Discovery,Molecular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12272-022-01422-1.pdf

Reference34 articles.

1. Bae JW, Kim MJ, Park YS, Myung CS, Jang CG, Lee SY (2007) Considerable interindividual variation in the pharmacokinetics of tolperisone HCl. Int J Clin Pharmacol Ther 45(2):110–113. https://doi.org/10.5414/cpp45110

2. Bae JW, Oh KY, Yoon SJ, Shin HB, Jung EH, Cho CK, Lim CW, Kang P, Choi CI, Jang CG, Lee SY, Lee YJ (2020) Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide. Arch Pharm Res 43(11):1207–1213. https://doi.org/10.1007/s12272-020-01293-4

3. Briskin BS, Dibirov MD, Evseev IuN, Novosel’tsev OS (2000) Treatment of chronic arterial insufficiency of legs with midocalm in elderly. Khirurgiia (mosk) 4:52–54

4. Byeon J, Lee JY, Jeon JS, Lee JE, Kim SH, Choi CI, Lee YJ, Bae JW, Jang CG, Lee SY (2013) Genetic polymorphism of CYP2D6 significantly affects the pharmacokinetics of tolperisone. Clinical Therapeutics 35(8):e58. https://doi.org/10.1016/j.clinthera.2013.07.158

5. Byeon JY, Kim YH, Lee CM, Kim SH, Chae WK, Jung EH, Choi CI, Jang CG, Lee SY, Bae JW, Lee YJ (2018) CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes. Arch Pharm Res 41(9):921–930. https://doi.org/10.1007/s12272-018-1075-6

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug–drug interactions with clarithromycin and paroxetine;Archives of Pharmacal Research;2024-04-25

2. Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism;Archives of Pharmacal Research;2023-12-30

3. PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes;Archives of Pharmacal Research;2023-12-27

4. Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes;Archives of Pharmacal Research;2023-12

5. Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone;Archives of Pharmacal Research;2023-08